Securities code: 002551 securities abbreviation: Shenzhen Glory Medical Co.Ltd(002551) Announcement No.: 2022-008
Bond Code: 128053 bond abbreviation: Shangrong convertible bond
Shenzhen Glory Medical Co.Ltd(002551)
Announcement on arbitration matters of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The arbitration stage of the case: the arbitration institution has accepted it.
2. Party status of the listed company: applicant.
3. Amount involved: 63686135.66 yuan (including 61301231.66 yuan of loan, 1786822.58 yuan of interest and 598081.42 yuan of liquidated damages; excluding lawyer’s fees and arbitration fees). 4. Whether it has a negative impact on the profits and losses of the listed company: because the arbitration has not been heard, it is impossible to predict the impact on the company’s profits in the current period or after the current period.
1、 Acceptance of this arbitration case
Shenzhen Glory Medical Co.Ltd(002551) (hereinafter referred to as “the company” or “the applicant”) submitted to the Shenzhen International Arbitration Court on July 16, 2021 and accepted the application for arbitration of the dispute over private lending with Xuchang Second People’s hospital. The accepted case number is (2021) Shenguo Zhongshou No. 3902. The company completed the arbitration acceptance procedures on January 13, 2022. The relevant matters are hereby announced as follows.
Applicant: Shenzhen Glory Medical Co.Ltd(002551)
Respondent: Xuchang Second People’s Hospital
Arbitration institution: Shenzhen International Arbitration Court (also known as South China International Economic and Trade Arbitration Commission and Shenzhen Arbitration Commission, formerly known as South China branch of China International Economic and Trade Arbitration Commission and Shenzhen Branch of China International Economic and Trade Arbitration Commission).
2、 Basic information of arbitration case
(I) arbitration claim
1. Order the respondent Xuchang Second People’s hospital to repay the loan fund of 61301231.66 yuan and pay interest of 1786822.58 yuan to the applicant according to law;
2. Order the respondent Xuchang Second People’s hospital to pay the applicant a penalty of 598081.42 yuan (temporarily calculated from the date of the unpaid amount payable to July 16, 2021, calculated according to 0.05% of the unpaid amount payable per day, and actually calculated to the date of paying off all the amount);
3. Order the respondent Xuchang Second People’s hospital to bear the lawyer’s fees paid by the applicant for this case in accordance with the law;
4. It ordered the respondent Xuchang Second People’s hospital to bear all the arbitration costs of the case according to law.
(II) facts and reasons
The applicant, the respondent and Xuchang municipal hospital jointly signed the loan agreement. According to the relevant regulations of the loan agreement, “the applicant lent the respondent a total of 107432000.69 yuan, and the loan term is 12 months from the date of lending”. After the signing of the loan agreement, the applicant has actually lent RMB 61301231.66 to the respondent in the manner agreed in the agreement, but the respondent has not fulfilled any contractual obligations such as repaying the loan funds and paying interest to the applicant under the loan agreement. In order to protect the legitimate rights and interests of the applicant, the applicant hereby initiates arbitration in accordance with the above legal provisions and the loan agreement.
3、 Awards in arbitration cases
As of the date of this announcement, the case has been accepted by Shenzhen International Arbitration Court and is planned to hold a hearing for arbitration on January 18, 2022.
4、 Other undisclosed litigation and arbitration matters
According to the relevant provisions of the stock listing rules of Shenzhen Stock Exchange: “major litigation and arbitration matters of listed companies shall be calculated cumulatively for 12 consecutive months”. As of the disclosure date of this announcement, in addition to the arbitration matters, the company and its holding subsidiaries have accumulated litigation and arbitration matters within 12 consecutive months. For details, see the company’s designated information disclosure newspapers China Securities Journal and securities times on January 12, 2022 Securities Daily, Shanghai Securities News and cninfo (www.cn. Info. Com. CN.), the designated information disclosure website Announcement on the company’s receipt of arbitration award (Announcement No.: 2022-004) disclosed on the. In addition, as of the date of this announcement, the company and its holding subsidiaries have no litigation and arbitration matters that should be disclosed but have not been disclosed.
5、 Possible impact of this arbitration on the company’s profits in the current period or after the current period
As this case has not been heard in court, the impact on the company’s profits in the current period or after the period is uncertain. The company will pay close attention to the performance of the above arbitration matters, earnestly safeguard the interests of the company and all shareholders, and timely perform the obligation of information disclosure in accordance with relevant rules. Please pay attention to investment risks.
6、 Documents for future reference
1. Notice on arbitration application issued by Shenzhen International Arbitration Court (No.: 202104103);
2. Notice of Arbitration (2021) issued by Shenzhen International Arbitration Court (szgz No. 3902-1);
3. Notice on the composition and opening of the arbitration tribunal (2021) issued by Shenzhen International Arbitration Court (szgzz No. 3902-3);
4. Payment receipt of arbitration fee.
It is hereby announced.
Shenzhen Glory Medical Co.Ltd(002551) board of directors
January 14, 2022
